References

Outcomes for patients with locally advanced pancreatic adenocarcinoma treated with stereotactic body radiation therapy versus conventionally fractionated radiation

10.1002/cncr.30706 · 2017 · External reference

Stereotactic body radiotherapy dose and its impact on local control and overall survival of patients for locally advanced intrahepatic and extrahepatic cholangiocarcinoma

10.1016/j.radonc.2018.11.015 · 2019 · External reference

Phase 2 multi-institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma

10.1002/cncr.29161 · 2015 · External reference

Stereotactic radiotherapy for unresectable adenocarcinoma of the pancreas

10.1002/cncr.24059 · 2009 · External reference

Stereotactic body radiation therapy for nonresectable tumors of the pancreas

10.1016/j.jss.2011.07.044 · 2012 · External reference

Simultaneous integrated protection: a new concept for high-precision radiation therapy

10.1007/s00066-016-1057-x · 2016 · External reference

The dancing cord: inherent spinal cord motion and its effect on cord dose in spine stereotactic body radiation therapy

10.1093/neuros/nyaa202 · 2020 · External reference

Limitations of the planning organ at risk volume (PRV) concept

10.1016/j.ijrobp.2006.05.009 · 2006 · External reference

Inter- and intrafraction motion assessment and accumulated dose quantification of upper gastrointestinal organs during magnetic resonance-guided ablative radiation therapy of pancreas patients

10.1016/j.phro.2022.02.007 · 2022 · External reference

Using adaptive magnetic resonance image-guided radiation therapy for treatment of inoperable pancreatic cancer

10.1002/cam4.2100 · 2019 · External reference

UK 2022 consensus on Normal tissue dose-volume constraints for oligometastatic, primary lung and hepatocellular carcinoma stereotactic ablative radiotherapy

10.1016/j.clon.2022.02.010 · 2022 · External reference

Fast and robust online adaptive planning in stereotactic MR-guided adaptive radiation therapy (SMART) for pancreatic cancer

10.1016/j.radonc.2017.07.028 · 2017 · External reference

Planning organ at risk volume margins for organ motion of the intestine

10.1016/j.radonc.2006.07.039 · 2006 · External reference

Evaluation of short-term gastrointestinal motion and its impact on dosimetric parameters in stereotactic body radiation therapy for pancreatic cancer

2023 · External reference

Pancreatic cancer treated with SBRT: effect of anatomical interfraction variations on dose to organs at risk

10.1016/j.radonc.2019.01.020 · 2019 · External reference

Dosimetric uncertainties resulting from Interfractional anatomic variations for patients receiving pancreas stereotactic body radiation therapy and cone beam computed tomography image guidance

10.1016/j.ijrobp.2021.08.002 · 2021 · External reference

Margins for geometric uncertainty around organs at risk in radiotherapy

10.1016/s0167-8140(02)00015-4 · 2002 · External reference

Dose prescription and reporting in stereotactic body radiotherapy: a multi-institutional study

10.1016/j.radonc.2023.109571 · 2023 · External reference

Variation in current prescription practice of stereotactic body radiotherapy for peripherally located early stage non-small cell lung cancer: recommendations for prescribing and recording according to the ACROP guideline and ICRU report 91

10.1016/j.radonc.2019.11.001 · 2020 · External reference

Stereotactic body radiotherapy for moderately central and ultra-central oligometastatic disease: initial outcomes

10.1016/j.tipsro.2020.01.002 · 2020 · External reference

Determining planning priorities for SABR for oligometastatic disease: a secondary analysis of the SABR-COMET phase II randomized trial

10.1016/j.ijrobp.2022.01.002 · 2022 · External reference

Intrafraction organ movement in adaptive MR-guided radiotherapy of abdominal lesions – dosimetric impact and how to detect its extent in advance

10.1186/s13014-024-02466-x · 2024 · External reference

An evaluation of motion mitigation techniques for pancreatic SBRT

10.1016/j.radonc.2017.05.013 · 2017 · External reference

Dosimetric impact of gastrointestinal tract variability during online adaptive MR-guided Hypofractionated stereotactic ablative radiotherapy (SABR) to the pancreas

10.1016/j.ijrobp.2022.07.2293 · 2022 · External reference

Online adaptive radiotherapy: assessment of planning technique and its impact on longitudinal plan quality robustness in pancreatic cancer

10.1016/j.radonc.2023.109869 · 2023 · External reference